Quick Takeaways
- Chione Ltd has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $16,741,549.
- Recent insider filing activity is available below.
- Info
- Significant Ownership
- Insider Ownership
Insider Trading & Ownership of Chione Ltd
- Location
- Larnaca, Cyprus
- Summary
- The estimated value of insider holdings of Chione Ltd is at least $16,741,549 dollars as of 28 Jun 2023. Chione Ltd is the 10%+ Owner of Acrivon Therapeutics, Inc. and owns shares of Acrivon Therapeutics, Inc. (ACRV) stock worth about $16.74M.
- Signature
- Chione Limited, by /s/ Shalom Leaf, as attorney-in fact by power of attorney
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Chione Ltd and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Acrivon Therapeutics, Inc. ($16,741,549).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Chione Ltd
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ACRV | Acrivon Therapeutics, Inc. | 10%+ Owner | $16,741,549 | 26 Jun 2023 |
Insider Transactions Reported by Chione Ltd:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.